| Issue |
Section |
Title |
File |
| Vol 17, No 3 (2018) |
CLINICAL OBSERVATIONS |
The use of preventive pleurodesis in patient with Langerhans-cell histiocytosis with lung involvement: the case report and the review |
(Rus)
|
| Vol 18, No 2 (2019) |
PROMISING STUDIES |
αβ-T-cell-depleted haploidentical hematopoietic stem cell transplantation in children with chemorefractory acute myeloid leukemia |
(Rus)
|
| Vol 19, No 1 (2020) |
PROMISING STUDIES |
The results of treatment in children with AML and initial hyperleucocytosis according to the AML-MM-2006 Protocol |
(Rus)
|
| Vol 19, No 1 (2020) |
ORIGINAL ARTICLES |
Use of romiplostim for newly diagnosed immune thrombocytopenia in children |
(Rus)
|
| Vol 20, No 1 (2021) |
ORIGINAL ARTICLES |
Results of the use of cladribine in children with acute myeloid leukemia in the treatment according to the AML-MM-2006 protocol |
(Rus)
|
| Vol 20, No 3 (2021) |
ORIGINAL ARTICLES |
Thrombopoietin receptor agonists for the treatment of severe persistent and chronic immune trombocytopenia in children: clinical data of Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology, Immunology |
(Rus)
|
| Vol 20, No 3 (2021) |
ORIGINAL ARTICLES |
Thrombopoietin receptor agonists for the treatment of severe persistent and chronic immune trombocytopenia in children: clinical data of Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology, Immunology |
(Rus)
|
| Vol 21, No 1 (2022) |
ORIGINAL ARTICLES |
The outcomes of children with acute myeloid leukemia treated in accordance with the AML–MM-2006 protocol |
(Rus)
|
| Vol 22, No 1 (2023) |
CLINICAL OBSERVATIONS |
Resistance to BRAF inhibitors in a patient with BRAF V600E-positive Langerhans cell histiocytosis |
(Rus)
|
| Vol 22, No 1 (2023) |
PROMISING STUDIES |
The use of droplet digital polymerase chain reaction for the molecular diagnosis and monitoring of treatment response in patients with Langerhans cell histiocytosis with the BRAF V600E mutation |
(Rus)
|
| Vol 22, No 2 (2023) |
CLINICAL OBSERVATIONS |
Daratumumab in the treatment of pure red cell aplasia after pediatric allogeneic stem cell transplantation |
(Rus)
|
| Vol 22, No 4 (2023) |
ORIGINAL ARTICLES |
Clinicogenomic associations in patients with Langerhans cell histiocytosis: a cohort study |
(Rus)
|
| Vol 23, No 1 (2024) |
ORIGINAL ARTICLES |
The results of a study on the effectiveness 37 and safety of treatment with vemurafenib and cytarabine/2-chloro-2′-deoxyadenosine combination in patients with Langerhans cell histiocytosis with BRAFV600E mutation |
(Rus)
|
| Vol 23, No 2 (2024) |
ORIGINAL ARTICLES |
Allogeneic hematopoietic stem cell transplantation outcomes in pediatric patients with refractory acute myeloid leukemia |
(Rus)
|
| Vol 23, No 4 (2024) |
ORIGINAL ARTICLES |
Thrombocytopenia of newborns: an observational study |
(Rus)
|
| Vol 24, No 1 (2025) |
ORIGINAL ARTICLES |
The prognostic significance of partner genes and breakpoint locations in children with KMT2A-rearranged acute myeloid leukemia |
(Rus)
|
| Vol 24, No 1 (2025) |
ORIGINAL ARTICLES |
Preliminary results of treatment of intermediate-risk patients according to the AML-MRD-2018 protocol |
(Rus)
|
| Vol 24, No 1 (2025) |
ORIGINAL ARTICLES |
Outcomes of treatment of childhood acute promyelocytic leukemia according to the APL 2003/2008 protocols in Russia and Belarus |
(Rus)
|
| Vol 24, No 1 (2025) |
CLINICAL OBSERVATIONS |
Acute myeloid leukemia with translocations involving the KMT2A gene in twins as a model for the study of leukemogenesis: clinical case reports and genetic characteristics |
(Rus)
|
